DUBLIN–(BUSINESS WIRE)–The “Cannabis Pharmaceuticals Market Research Report by Brand, by Product Type, by Distribution Channel, by Application, by State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.
The United States Cannabis Pharmaceuticals Market size was estimated at USD 168.41 million in 2020, is expected to reach USD 209.88 million in 2021, and is projected to grow at a CAGR of 21.21% to reach USD 647.53 million by 2027.
In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.
Cumulative Impact of COVID-19:
The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cannabis Pharmaceuticals Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space.
It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Cannabis Pharmaceuticals Market, including
- AbbVie Inc.
- Amyris, Inc.
- Aphria, Inc.
- Aurora Cannabis, Inc.
- Botanix Pharmaceuticals
- Breath of Life Pharma, Ltd.
- Cannabis Science, Inc.
- Canopy Growth Corporation
- Cara Therapeutics
- CB Therapeutics Inc.
- Corbus Pharmaceuticals Holdings, Inc.
- Cronos Group Inc.
- GW Pharmaceuticals, PLC
- Insys Therapeutics, Inc.
- Medical Marijuana Inc.
- Medicure Pharmaceuticals
- MedReleaf Corp.
- MGC Pharmaceuticals Limited
- Pascal Biosciences Inc.
- PharmaCyte Biotech, Inc.
- Serina Therapeutics, Inc.
- Teva Pharmaceutical Industries Ltd.
- Tilray, Inc.
- Valeant Pharmaceuticals
- Zynerba Pharmaceuticals, Inc.
Key Topics Covered:
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Cannabis Pharmaceuticals Market, by Brand
6.1. Introduction
6.2. Epidiolex
6.3. Sativex
7. Cannabis Pharmaceuticals Market, by Product Type
7.1. Introduction
7.2. Ointments & Creams
7.3. Solids and Dissolvable Powder & Oil
8. Cannabis Pharmaceuticals Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies
9. Cannabis Pharmaceuticals Market, by Application
9.1. Introduction
9.2. Arthritis
9.3. Cancer
9.4. Epilepsy
9.5. Migraine
10. California Cannabis Pharmaceuticals Market
11. Florida Cannabis Pharmaceuticals Market
12. Illinois Cannabis Pharmaceuticals Market
13. New York Cannabis Pharmaceuticals Market
14. Ohio Cannabis Pharmaceuticals Market
15. Pennsylvania Cannabis Pharmaceuticals Market
16. Texas Cannabis Pharmaceuticals Market
17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion
18. Company Usability Profiles
For more information about this report visit https://www.researchandmarkets.com/r/nh7gtr
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900